MediciNova, Inc.
MNOV
$1.51
$0.042.72%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 257.90K | 134.60K | -- | -- | 0.00 |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 257.90K | 134.60K | -- | -- | 0.00 |
| Cost of Revenue | 231.60K | 116.30K | -- | -- | -- |
| Gross Profit | 26.30K | 18.30K | -- | -- | 0.00 |
| SG&A Expenses | 5.88M | 5.53M | 5.49M | 5.48M | 5.04M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 13.63M | 13.44M | 12.74M | 12.68M | 11.98M |
| Operating Income | -13.37M | -13.30M | -12.74M | -12.68M | -11.98M |
| Income Before Tax | -12.00M | -11.81M | -11.15M | -11.04M | -10.29M |
| Income Tax Expenses | 5.50K | 5.50K | 5.50K | 5.50K | 3.00K |
| Earnings from Continuing Operations | -12.01 | -11.81 | -11.16 | -11.05 | -10.29 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -12.01M | -11.81M | -11.16M | -11.05M | -10.29M |
| EBIT | -13.37M | -13.30M | -12.74M | -12.68M | -11.98M |
| EBITDA | -13.35M | -13.28M | -12.72M | -12.65M | -11.96M |
| EPS Basic | -0.24 | -0.24 | -0.23 | -0.23 | -0.21 |
| Normalized Basic EPS | -0.15 | -0.15 | -0.14 | -0.14 | -0.13 |
| EPS Diluted | -0.25 | -0.24 | -0.23 | -0.23 | -0.21 |
| Normalized Diluted EPS | -0.15 | -0.15 | -0.14 | -0.14 | -0.13 |
| Average Basic Shares Outstanding | 196.18M | 196.18M | 196.18M | 196.18M | 196.18M |
| Average Diluted Shares Outstanding | 196.18M | 196.18M | 196.18M | 196.18M | 196.18M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |